Immune to Cancer: The CRI Blog
-
Immune Cell Triads Unveil a Critical Role in Fighting Solid Tumors
The Cancer Research Institute (CRI) is excited to share the latest study from CRI Lloyd J. Old… -
July is Sarcoma Awareness Month – Here’s What You Need to Know
Sarcomas are a complex type of cancer that can trick the body into thinking the tumor is… -
10 Attractions to Visit in and around Washington, D.C. While Attending CICON24
The eighth annual CRI-ENCI Cancer Immunotherapy Conference (CICON24) kicks off on September 8 in National Harbor, Maryland…. -
Journey Through the Highlights of the 12th Annual Cancer Immunotherapy Month™
Each June, CRI invites its global community of scientists, caretakers, patients, and more to take part in… -
FDA approves EPKINLY® for relapsed or refractory follicular lymphoma
June 26, 2024, marked a milestone for patients suffering from follicular lymphoma. The FDA approved Genmab’s epcoritamab-bysp… -
What’s in Your Glass? Weighing the Health Risks of Alcohol Consumption
“Just one for the road.” We’ve all heard or said this at a party. Alcohol is a… -
CRI’s 5th Annual Wear White Luncheon Raises Over $40,000
On Thursday, June 20, 2024, the Cancer Research Institute (CRI) celebrated its fifth annual Wear White Luncheon,… -
Keytruda Receives 40th FDA Approval
This week marked a significant milestone in the fight against cancer. On June 17, the FDA approved… -
#Immune2Cancer Day Ignites Support for CRI
The cornerstone of Cancer Immunotherapy MonthTM is #Immune2Cancer Day, June 14, a day dedicated to showcasing the…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.